Press Releases

Qvirus Platform Designed Customized AAV Testing Services to Accelerate The Development of Viral Vaccine and Gene Therapy

Creative Biogene Provides Reliable and High Quality Pseudovirus Services to Support The Studies of SARS-CoV-2

Optimer® diagnostic reagent detects omicron variant

Aptamer Group, the developer of novel Optimer® binders to enable innovation in the life sciences industry, has demonstrated that its Optimer to the S1 subunit of SARS-CoV-2 Spike protein is able to detect the Omicron variant. This Optimer binder is available to diagnostic developers to enable new diagnostic assays and improve the sensitivity of current COVID-19 diagnostics to support the ongoing pandemic. In addition, other novel Optimer binders from Aptamer Group can also provide a highly effective antibody-alternative for diagnostics, with excellent target recognition, consistent supply and temperature stability for simple global logistics.

Johari Digital Healthcare inaugurated the ‘Johari Center of Excellence’ in IIT Jodhpur Technology Park

Most research and innovations from Academia end up in publications or are shelved, but now with Industry and academia collaboration it will have chance to get converted into a real product through engineering and transfer to manufacturing cycle along with required regulatory compliances.

Indica Labs’ HALO AP® platform achieves CE-IVD certification for use in primary diagnosis

Indica Labs has announced that following ISO13485 certification, HALO AP® has received a CE Mark for use in primary diagnosis within the European Economic Area, Switzerland, and the UK.

Hoth Therapeutics Sign API and Drug Product Contracts with WuXi STA to Advance Manufacturing of HT-KIT

ATMPS and Assurea LLC launch strategic collaboration for advanced therapy supply chain

New product: Thermo Fisher introduces Myeloid Assays for rapid profiling

CCD specialist, Atik Cameras launches the TE-77 advanced scientific solution, using new CCD technology from Teledyne e2v

Atik Cameras has launched the first in its advanced imaging solutions, the TE-77 CCD sensor.

Inceptua receives approval of marketing authorization transfer of Apealea® (paclitaxel micellar) for the treatment of ovarian cancer

Inceptua Group has announced that the European Commission (EC) and the UK Medicines and Healthcare products Regulatory Agency (MHRA) has approved the transfer of the marketing authorization for Apealea® (paclitaxel micellar) from Oasmia Pharmaceutical AB to Inceptua AB

Panthera leads the way in the UK with specialist research sites for NASH and NAFLD studies

Panthera leads the way in the UK with specialist research sites for NASH and NAFLD studies

Alfa Chemistry Releases a Series of Nanoprisms

Alfa Chemistry Catalysts: Chiral N-Heterocyclic Carbenes (NHC) Are Now Available for Organic Synthesis

AusDiagnostics launches new addition to the Puryx® and MT-Prep™ extraction product lines

AusDiagnostics, a leading biotechnology company specialising in molecular diagnostics, has today launched Puryx® Access – the latest addition to the popular Puryx® extraction product line.

UK med tech firm secures £1 million funding boost

UK medtech firm Bond Digital Health has secured a further £1 million cash injection to support its plans for growth. The Wales-based company has developed a data capture and management system for lateral flow diagnostic tests.

Epigenetics Data Analysis Service Now Available by CD Genomics’s Bioinformatics-Analysis Platform

Bioinformatics-analysis Platform is a leading open solution for data-driven innovation, which aims to discover the hidden potential in biological data and unearth new insights or predict new prospects related to life science research. CD Genomics has recently announced Epigenetics Data Analysis to move your disease research forward.

DDA Platform Offers Wide Range of Genetoxicity Testing Services to Accelerate Different Phases of Drug Discovery

Acroscell Offers Cardiac Ion Channel Screen Panels to Detect and Analyze Effects of Candidate Drugs

Creative Bioarray Develops State-of-art Cell Based Assay to Support Biomedical Research and Drug-discovery Process

Microbialtec Platform Develops Chemotaxonomy-based Drug Discovery to Accelerate The Development of Drug Discovery